Viridian raises $359M through equity and convertible debt to repay loans, fund R&D expansion

Filed May 11, 2026 · Period ending May 6, 2026 · ~1 min read

Key Changes

• high

  Completed $250M convertible notes offering at 1.75% due 2032, convertible at $24.65/share (45% premium to $17 equity price). Up to 14.7M shares could be issued if all notes convert, representing significant potential dilution.

  Item 1.01: Convertible Notes verify on EDGAR →
• high

  Raised $117M through equity offering of 7.4M shares at $17/share. Combined with convertible notes, total capital raise of approximately $359M provides substantial runway for operations.

  Item 8.01: Equity Offering verify on EDGAR →
• high

  Proceeds will repay all outstanding debt with Hercules Capital from 2022 loan agreement, eliminating debt obligations and interest expense while improving financial flexibility.

  Item 8.01: Use of Proceeds verify on EDGAR →